Back to Search Start Over

KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples

Authors :
Herbert Ho-Fung Loong
Ming Yao
Lunxu Liu
Jian Guo
Jicheng Yao
Xianfeng Jin
Tao Jiang
Yutong Xing
Gen Lin
Tony Mok
Mingjiang Li
Chunyan Cheng
Nan Du
Zhihua Shi
Hanqing Lin
Yanzhi Cui
Kai Wang
Source :
Transl Lung Cancer Res
Publication Year :
2020
Publisher :
AME Publishing Company, 2020.

Abstract

Background Kirsten rat sarcoma vial oncogene (KRAS) is one of the most prevalent oncogenes in multiple cancer types, but the incidence is different between the Asian and non-Asian populations. The recent development of KRAS G12C targeting drug has shown great promise. It is thus important to understand the genomic landscape of KRAS G12C in a specific population. Methods Sequencing data of 11,951 tumor samples collected from 11/2016 to 7/2019 from multiple centres in China were analyzed for KRAS mutation status. Concomitant genomic aberrations were further analyzed in tumors with KRAS G12C mutations, which were sequenced with comprehensive cancer panel including over 450 cancer-related genes. Smoking status and its correlation with KRAS were analyzed in 2,235 lung cancer cases within this cohort. Results KRAS mutations were identified in 1978 (16.6%) patient samples. Specifically, KRAS G12C accounted for 14.5% (n=286) of all KRAS mutations. G12C was most commonly seen in lung cancer (4.3%), followed by colorectal cancer (2.5%) and biliary cancer (2.3%). Almost all patients (99.6%) with G12C mutations had concomitant genomic aberrations. These were most commonly associated with the RAS/RTK pathway including BRAF and PI3KCA mutations. Moreover, KRAS mutation was positively correlated with smoking status in lung adenocarcinomas. Conclusions The overall incidence of KRAS G12C mutations remains low in the Chinese population. The most common tumor types harboring KRAS G12C mutations are in patients suffering from lung, colorectal and biliary cancers.

Details

ISSN :
22264477 and 22186751
Volume :
9
Database :
OpenAIRE
Journal :
Translational Lung Cancer Research
Accession number :
edsair.doi.dedup.....05d33215fdf1d7e47005bb0a5b7e3557